Roland Blanqué

991 total citations
31 papers, 559 citations indexed

About

Roland Blanqué is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Roland Blanqué has authored 31 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Immunology. Recurrent topics in Roland Blanqué's work include Cytokine Signaling Pathways and Interactions (6 papers), Immune Response and Inflammation (6 papers) and Inflammatory mediators and NSAID effects (5 papers). Roland Blanqué is often cited by papers focused on Cytokine Signaling Pathways and Interactions (6 papers), Immune Response and Inflammation (6 papers) and Inflammatory mediators and NSAID effects (5 papers). Roland Blanqué collaborates with scholars based in Belgium, France and Australia. Roland Blanqué's co-authors include Carol R. Gardner, Colin Gardner, Pierre Deprez, Jean H.M. Feyen, Bertrand Heckmann, Patrick Mollat, Philippe Clément-Lacroix, Ellen van der Aar, Yoshifumi Suzuki and Hiroaki Saito and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Medicinal Chemistry and Annals of the Rheumatic Diseases.

In The Last Decade

Roland Blanqué

30 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roland Blanqué Belgium 13 308 178 85 80 68 31 559
Toshihiro Imamura Japan 14 592 1.9× 192 1.1× 122 1.4× 131 1.6× 48 0.7× 27 880
Asta Valančiūtė France 11 281 0.9× 86 0.5× 106 1.2× 124 1.6× 43 0.6× 15 706
Joanne Uhl United States 12 277 0.9× 84 0.5× 71 0.8× 87 1.1× 62 0.9× 19 587
Wataru Hirose Japan 16 240 0.8× 108 0.6× 55 0.6× 219 2.7× 191 2.8× 52 724
Virginia Novaro Argentina 19 375 1.2× 246 1.4× 135 1.6× 102 1.3× 14 0.2× 42 907
Paul W. Fisher United States 14 206 0.7× 101 0.6× 34 0.4× 61 0.8× 63 0.9× 17 504
Susan Goorden Netherlands 15 398 1.3× 57 0.3× 57 0.7× 50 0.6× 26 0.4× 27 741
Sandra J. Hoffman United States 14 566 1.8× 300 1.7× 78 0.9× 45 0.6× 83 1.2× 25 872
Shunying Zhu China 15 342 1.1× 230 1.3× 57 0.7× 121 1.5× 26 0.4× 32 792
Marta Zalacaín Spain 15 325 1.1× 229 1.3× 153 1.8× 86 1.1× 33 0.5× 20 714

Countries citing papers authored by Roland Blanqué

Since Specialization
Citations

This map shows the geographic impact of Roland Blanqué's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland Blanqué with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland Blanqué more than expected).

Fields of papers citing papers by Roland Blanqué

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roland Blanqué. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland Blanqué. The network helps show where Roland Blanqué may publish in the future.

Co-authorship network of co-authors of Roland Blanqué

This figure shows the co-authorship network connecting the top 25 collaborators of Roland Blanqué. A scholar is included among the top collaborators of Roland Blanqué based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roland Blanqué. Roland Blanqué is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anquetil, Florence, Roland Blanqué, Daisy Liekens, et al.. (2025). GLPG2737, a CFTR Inhibitor, Prevents Cyst Growth in Preclinical Models of Autosomal Dominant Polycystic Kidney Disease. American Journal of Nephrology. 56(6). 1–17.
2.
Blanqué, Roland, Kenji F. Shoji, Monica Borgonovi, et al.. (2024). Discovery of GLPG3667, a Selective ATP Competitive Tyrosine Kinase 2 Inhibitor for the Treatment of Autoimmune Diseases. Journal of Medicinal Chemistry. 67(11). 8545–8568. 5 indexed citations
3.
Morand, Eric F., Roland Blanqué, Kenji F. Shoji, et al.. (2023). AB0144 PHARMACOLOGICAL CHARACTERIZATION OF GLPG3667, A SELECTIVE TYK2 INHIBITOR, SUPPORTS DEVELOPMENT IN DERMATOMYOSITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS. Annals of the Rheumatic Diseases. 82. 1251–1252. 1 indexed citations
4.
Little, Christopher B., Margaret M. Smith, Patrick Mollat, et al.. (2021). Pharmacological characterization of GLPG1972/S201086, a potent and selective small-molecule inhibitor of ADAMTS5. Osteoarthritis and Cartilage. 30(2). 291–301. 22 indexed citations
5.
Taneja, Amit, Julie Desrivot, Paul M. Diderichsen, et al.. (2019). Population Pharmacokinetic and Pharmacodynamic Analysis of GLPG1690, an Autotaxin Inhibitor, in Healthy Volunteers and Patients with Idiopathic Pulmonary Fibrosis. Clinical Pharmacokinetics. 58(9). 1175–1191. 10 indexed citations
6.
Lepescheux, L., Monica Borgonovi, Patrick Mollat, et al.. (2018). ADAMTS-5 inhibition with the potent and highly selective inhibitor GLPG1972 results in strong disease-modifying OA drug effects in the rat meniscectomy model. Osteoarthritis and Cartilage. 26. S26–S26. 4 indexed citations
7.
Little, Christopher B., Roland Blanqué, Patrick Mollat, et al.. (2017). GLPG1972: a potent, selective, orally available adamts-5 inhibitor for the treatment of OA. Osteoarthritis and Cartilage. 25. S58–S59. 13 indexed citations
8.
Vanhoutte, Frédéric, Sonia Dupont, Roland Blanqué, et al.. (2015). P612. Human safety, pharmacokinetics and pharmacodynamics of the GPR84 antagonist GLPG1205, a potential new approach to treat IBD.. Journal of Crohn s and Colitis. 9(suppl 1). S387–S387. 3 indexed citations
9.
Dupont, Sonia, Ingrid Arijs, Roland Blanqué, et al.. (2015). GPR84 inhibition as a novel therapeutic approach in IBD: mechanistic and translational studies. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
10.
Blanqué, Roland, L. Lepescheux, Marielle Auberval, et al.. (2014). Characterization of GLPG0492, a selective androgen receptor modulator, in a mouse model of hindlimb immobilization. BMC Musculoskeletal Disorders. 15(1). 291–291. 21 indexed citations
11.
Horst, Geertje van der, Christel van den Hoogen, Jeroen T. Buijs, et al.. (2011). Targeting of αv-Integrins in Stem/Progenitor Cells and Supportive Microenvironment Impairs Bone Metastasis in Human Prostate Cancer. Neoplasia. 13(6). 516–IN9. 91 indexed citations
12.
Aoki, Kazuhiro, Hiroaki Saito, Cécile Itzstein, et al.. (2006). A TNF receptor loop peptide mimic blocks RANK ligand–induced signaling, bone resorption, and bone loss. Journal of Clinical Investigation. 116(6). 1525–1534. 113 indexed citations
13.
Gardner, Colin, et al.. (2001). Mechanisms involved in prostaglandin-induced increase in bone resorption in neonatal mouse calvaria. Prostaglandins Leukotrienes and Essential Fatty Acids. 64(2). 117–125. 12 indexed citations
14.
Blanqué, Roland, et al.. (2001). Phasic production of urinary pyridinium crosslinks in mice: The effect of ovariectomy. Calcified Tissue International. 68(2). 102–108. 2 indexed citations
15.
Roux, Christian, et al.. (2001). Bone-Resorbing Cytokines from Peripheral Blood Mononuclear Cells after Hormone Replacement Therapy: A Longitudinal Study. Osteoporosis International. 12(9). 769–776. 32 indexed citations
16.
Paysant, Jérôme, Roland Blanqué, Marc Vasse, et al.. (2000). FACTORS INFLUENCING THE EFFECT OF THE SOLUBLE IL-6 RECEPTOR ON IL-6 RESPONSES IN HepG2 HEPATOCYTES. Cytokine. 12(6). 774–779. 22 indexed citations
17.
Blanqué, Roland, et al.. (1999). Dual mechanisms of action of interferon-γ in potentiating responses to LPS in mice IL1, TNFα and IL6 production in serum and hypothermia. General Pharmacology The Vascular System. 32(4). 453–461. 12 indexed citations
18.
Blanqué, Roland, et al.. (1998). Increases in osteocalcin after ovariectomy are amplified by LPS injection: Strain differences in bone remodelling. General Pharmacology The Vascular System. 30(1). 51–56. 9 indexed citations
19.
Blanqué, Roland, et al.. (1997). Effects of SK&F 86002 on cytokine-stimulated IL6 production in cultured neonatal mouse calvaria and SaOS2 osteoblastic cells: the role of prostaglandins and other mechanisms of action.. PubMed. 23(2). 63–70. 8 indexed citations
20.
Blanqué, Roland, et al.. (1996). Hypothermia as an indicator of the acute effects of lipopolysaccharides: comparison with serum levels of IL1β, IL6 and TNFα. General Pharmacology The Vascular System. 27(6). 973–977. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshihiro Imamura Breakdown of academic impact, for papers by Asta Valančiūtė Breakdown of academic impact, for papers by Joanne Uhl Breakdown of academic impact, for papers by Wataru Hirose Breakdown of academic impact, for papers by Virginia Novaro Breakdown of academic impact, for papers by Paul W. Fisher Breakdown of academic impact, for papers by Susan Goorden Breakdown of academic impact, for papers by Sandra J. Hoffman Breakdown of academic impact, for papers by Shunying Zhu Breakdown of academic impact, for papers by Marta Zalacaín
Rankless by CCL
2026